Human T-Cell Lymphotropic Virus (HTLV)
Human T-Cell Lymphotropic Virus (HTLV) (9823-08)
Learn about the characteristics, worldwide seroprevalence, transmission and diseases associated with these human retroviruses and discover how detection has impacted transfusion medicine.
| Code |
9823-08 |
| Niveau |
Supérieur |
Prix membres
$0
Prix non-membres
$135
Renseignements additionnels
PEP hours: 11
CPS/ART credits: 0.8
Learning Outcomes:
- Describe the discovery of the Human T-Cell Lymphotropic Viruses
- Characterize the HTLV virus: family, viral structure, and genomic structure
- Give details of the reported worldwide seroprevalence of HTLV
- Discuss the factors that influence seroprevalence in the community
- Identify the problems of getting an accurate picture of the worldwide distribution of HTLV
- Describe the modes of transmission of the virus
- List the diseases associated with the HTLV viruses
- Describe the transfusion transmitted infection
- Describe the rationale for screening blood donors for HTLV antibody status
- Give details of the transfusion transmission rates and the factors affecting transmission
- Describe the testing methods used to screen for the presence of the viruses
- Describe the testing methods available to confirm the screening assay results
- Discuss the findings of published method evaluations
- Describe the approach to the management and treatment of patients seropositive for HTLV
Instructor: John Chapman, FCSMLS, FIMLS, CLSp(H)
Prerequisites: None
Textbook: N/A
Equipment: Computer with Internet is required
Start Date: Upon registration
Completion: Up to 52 weeks
Version Date: March 2008